Reviews 12
Filters:
Rating
Language
Sort:
Most recent
P
8 months ago

Kartos Therapeutics is an outstanding company in t...

Kartos Therapeutics is an outstanding company in the biotech industry. Their dedication to advancing healthcare through innovative drug development is commendable. The website offers a wealth of information, and their team's expertise is evident. Keep up the excellent work!

T
9 months ago

I've had the pleasure of discovering Kartos Therap...

I've had the pleasure of discovering Kartos Therapeutics' website recently, and let me tell you, it's a goldmine of knowledge! The information presented is clear, concise, and easily accessible. Their dedication to improving healthcare through innovative drug development is truly inspiring.

D
10 months ago

I stumbled upon a biotech company that fascinated ...

I stumbled upon a biotech company that fascinated me. The company's website, despite lacking the company's name, had a sleek and modern design. The information provided was concise and easy to understand. However, I would have appreciated additional details regarding their research goals.

A
11 months ago

😊 Kartos Therapeutics is doing an amazing job in t...

😊 Kartos Therapeutics is doing an amazing job in the field of biotech. Their website provides comprehensive information that helps demystify the science behind their groundbreaking research. I am really impressed with their dedication and expertise. Keep up the good work! 👌

F
1 year ago

👍 I visited Kartos Therapeutics' website and found...

👍 I visited Kartos Therapeutics' website and found their products intriguing. The descriptions were informative and helpful. However, I would have liked to see more detailed explanations about the underlying science. Overall, it was a decent experience.

N
1 year ago

I've been following Kartos Therapeutics for some t...

I've been following Kartos Therapeutics for some time now, and I must say they never cease to amaze me. Their commitment to innovation and passion for improving lives is truly admirable. The website is informative and user-friendly, providing valuable insights into their groundbreaking work. Highly recommend!

S
1 year ago

I recently discovered this amazing biotech firm th...

I recently discovered this amazing biotech firm through a friend. I was really impressed with their innovative approach and cutting-edge technologies. The quality of their work is outstanding, and their team is incredibly knowledgeable. I'm glad to have found Kartos Therapeutics, they are truly a game-changer!

R
1 year ago

I had a really positive experience with Kartos The...

I had a really positive experience with Kartos Therapeutics. Their website is user-friendly and easy to navigate. The information provided about their products and services is clear and comprehensive. The customer support team was helpful and responsive to my inquiries. Overall, I highly recommend Kartos Therapeutics!

S
1 year ago

Kartos Therapeutics has exceeded my expectations i...

Kartos Therapeutics has exceeded my expectations in terms of their dedication to scientific advancement in the biotech field. Their website offers a comprehensive overview of their work, and their team's expertise is evident in their achievements. Truly impressive!

B
1 year ago

I came across a biotech company that caught my int...

I came across a biotech company that caught my interest. The website was user-friendly, and their products seemed promising. However, I felt that the information provided lacked depth and could've been more detailed. Overall, a decent experience, but room for improvement.

D
1 year ago

👍 Kartos Therapeutics is a company that impressed ...

👍 Kartos Therapeutics is a company that impressed me right from the start. The website was easy to navigate, and their research focus really caught my attention. The team's expertise is evident, and I'm confident in their ability to make a positive impact in the biotech industry.

About Kartos therapeutics

Kartos Therapeutics: Revolutionizing Cancer Treatment with Innovative MDM2 Inhibitor

Kartos Therapeutics is a clinical stage biopharmaceutical company that is dedicated to developing innovative cancer treatments. The company's primary focus is on the development of an investigational MDM2 inhibitor, navtemadlin (KRT-232), which has shown promising results in preclinical and clinical studies.

MDM2 (mouse double minute 2 homolog) is a protein that plays a critical role in regulating the activity of p53, a tumor suppressor gene. In normal cells, p53 helps prevent the formation and growth of tumors by inducing cell cycle arrest or apoptosis (programmed cell death) when DNA damage occurs. However, in many types of cancer, the function of p53 is impaired due to mutations or other alterations that disrupt its activity.

MDM2 inhibitors are designed to restore the function of p53 by blocking its interaction with MDM2 and promoting its activation. This approach has been shown to be effective in preclinical models and early-stage clinical trials for various types of cancer.

Navtemadlin (KRT-232) is Kartos' lead product candidate and an orally available small molecule inhibitor of MDM2. It has demonstrated potent antitumor activity in preclinical models against several types of solid tumors and hematological malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), lymphoma, and multiple myeloma.

In phase 1/2a clinical trials conducted so far, navtemadlin has shown promising safety profile as well as encouraging efficacy signals across multiple tumor types. The ongoing phase 1b/2 study aims to evaluate navtemadlin's safety and efficacy as monotherapy or combination therapy with other agents for patients with relapsed/refractory AML or high-risk MDS who have failed standard therapies.

Apart from navtemadlin, Kartos also has a pipeline of other novel compounds targeting different aspects of cancer biology such as DNA damage response pathways that are being developed for potential future use alone or in combination with existing therapies.

The team at Kartos Therapeutics comprises experienced scientists and clinicians who are passionate about advancing new treatments for patients suffering from cancer. They work closely together to identify new targets for drug development based on cutting-edge research insights into disease mechanisms.

In conclusion, Kartos Therapeutics represents an exciting opportunity for investors looking to support innovative approaches towards treating cancer using novel drugs like navtemadlin(KRT-232). With their strong scientific expertise combined with their commitment towards improving patient outcomes through rigorous research efforts - it's no wonder why they're quickly becoming one among top contenders within this space!

Kartos therapeutics

Kartos therapeutics

4.1